

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.72325377 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.36679954 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 9.17153107 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.57778272 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57778272 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.27390762 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27390762 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.80645974 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.52360753 |
| 10 | drug metabolic process (GO:0017144) | 6.24290861 |
| 11 | opsonization (GO:0008228) | 6.18463154 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.12727734 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.12727734 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.12727734 |
| 15 | kynurenine metabolic process (GO:0070189) | 6.03078173 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.91875526 |
| 17 | oxidative demethylation (GO:0070989) | 5.91280707 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.77793763 |
| 19 | regulation of plasminogen activation (GO:0010755) | 5.76828308 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.76738825 |
| 21 | urea metabolic process (GO:0019627) | 5.69488174 |
| 22 | urea cycle (GO:0000050) | 5.69488174 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.67702234 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.65617827 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.64650652 |
| 26 | ethanol metabolic process (GO:0006067) | 5.62835033 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.44028238 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.41536419 |
| 29 | protein carboxylation (GO:0018214) | 5.39736557 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.39736557 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.28474562 |
| 32 | cysteine metabolic process (GO:0006534) | 5.27182973 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.25777909 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 5.23358419 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.14270619 |
| 36 | regulation of humoral immune response (GO:0002920) | 5.12515255 |
| 37 | bile acid metabolic process (GO:0008206) | 5.07839555 |
| 38 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.02498142 |
| 39 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.02498142 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 5.00305227 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 5.00164174 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.96903434 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.94949766 |
| 44 | regulation of complement activation (GO:0030449) | 4.90303663 |
| 45 | negative regulation of protein activation cascade (GO:2000258) | 4.89048667 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.87090270 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.87090270 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.87090270 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86275274 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.81816170 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.78533296 |
| 52 | negative regulation of hemostasis (GO:1900047) | 4.78533296 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 4.74745009 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.74617816 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.69915275 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.69915275 |
| 57 | phospholipid efflux (GO:0033700) | 4.68702353 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.65510481 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.65332923 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.65332923 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.63478333 |
| 62 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.60952591 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.58861099 |
| 64 | lysine catabolic process (GO:0006554) | 4.54962561 |
| 65 | lysine metabolic process (GO:0006553) | 4.54962561 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 4.48351004 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.42655092 |
| 68 | glycine metabolic process (GO:0006544) | 4.41089616 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.34977565 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.34600518 |
| 71 | negative regulation of coagulation (GO:0050819) | 4.34290534 |
| 72 | S-adenosylmethionine metabolic process (GO:0046500) | 4.34080893 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 4.32959853 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.29598917 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 4.29344466 |
| 76 | cholesterol efflux (GO:0033344) | 4.28122803 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 4.23682423 |
| 78 | amine catabolic process (GO:0009310) | 4.23682423 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 4.22237725 |
| 80 | glutamate metabolic process (GO:0006536) | 4.21990280 |
| 81 | positive regulation of hemostasis (GO:1900048) | 4.21613040 |
| 82 | positive regulation of blood coagulation (GO:0030194) | 4.21613040 |
| 83 | cellular glucuronidation (GO:0052695) | 4.19113076 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 4.15703825 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 4.12827756 |
| 86 | arginine metabolic process (GO:0006525) | 4.06302642 |
| 87 | alkaloid metabolic process (GO:0009820) | 4.04469609 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 4.03167270 |
| 89 | fibrinolysis (GO:0042730) | 4.02704258 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99279744 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.98569269 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.98566499 |
| 93 | acute inflammatory response (GO:0002526) | 3.96876418 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.95649594 |
| 95 | ethanol oxidation (GO:0006069) | 3.94148682 |
| 96 | cofactor catabolic process (GO:0051187) | 3.92267568 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91463762 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91463762 |
| 99 | negative regulation of complement activation (GO:0045916) | 3.90448271 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.88721095 |
| 101 | drug catabolic process (GO:0042737) | 3.88010108 |
| 102 | ketone body metabolic process (GO:1902224) | 3.87868721 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.86197564 |
| 104 | positive regulation of coagulation (GO:0050820) | 3.85679436 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.84334472 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.77050906 |
| 107 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.76256883 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.75186320 |
| 109 | organic acid catabolic process (GO:0016054) | 3.75186320 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.74338499 |
| 111 | flavonoid metabolic process (GO:0009812) | 3.73191641 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.72356701 |
| 113 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71907607 |
| 114 | protein activation cascade (GO:0072376) | 3.71376995 |
| 115 | sterol homeostasis (GO:0055092) | 3.70587732 |
| 116 | glucuronate metabolic process (GO:0019585) | 3.70201465 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.70201465 |
| 118 | complement activation (GO:0006956) | 3.70005189 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69962298 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.68216816 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.64397664 |
| 122 | acetyl-CoA metabolic process (GO:0006084) | 3.61547892 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.60714410 |
| 124 | cytolysis (GO:0019835) | 3.60436902 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 3.59935886 |
| 126 | regulation of acute inflammatory response (GO:0002673) | 3.59662621 |
| 127 | heme transport (GO:0015886) | 3.58364642 |
| 128 | regulation of apoptotic cell clearance (GO:2000425) | 3.57037261 |
| 129 | acute-phase response (GO:0006953) | 3.55270096 |
| 130 | intestinal cholesterol absorption (GO:0030299) | 3.54421102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.47308693 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24985084 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.93636611 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53354874 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.41850403 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.14217572 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94941224 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09596374 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01416871 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04398624 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0511818 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98320799 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95820804 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57980794 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52225652 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47221033 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45643391 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41591293 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40573064 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28858352 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24205249 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24163382 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17019765 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12369633 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04034694 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01255122 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94058979 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91267856 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91208805 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86054716 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83140577 |
| 32 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82919865 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81640802 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81108769 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79388351 |
| 36 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78944638 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.78084974 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78037428 |
| 39 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77536431 |
| 40 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76790722 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75472764 |
| 42 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74823953 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74034294 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.72971076 |
| 45 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72555937 |
| 46 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70917462 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70507929 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69745894 |
| 49 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.68332192 |
| 50 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.68119668 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67456269 |
| 52 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.67386507 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66881514 |
| 54 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66767865 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65990199 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.65488704 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65461682 |
| 58 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.65417036 |
| 59 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65024806 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.64934171 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64383014 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64326355 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63948287 |
| 64 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.63887768 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.63688941 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62400149 |
| 67 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60985403 |
| 68 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.60635959 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.60631530 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60342206 |
| 71 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60122273 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.59485372 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59441893 |
| 74 | SA1_27219007_Chip-Seq_Bcells_Human | 0.59276376 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.58877585 |
| 76 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.57750933 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.56736999 |
| 78 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.56585204 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56312846 |
| 80 | NFYA_21822215_ChIP-Seq_K562_Human | 0.56289774 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55488418 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55488418 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.53670093 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.52585862 |
| 85 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.52515485 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52486032 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51899195 |
| 88 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51724101 |
| 89 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.51684113 |
| 90 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51236467 |
| 91 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50480321 |
| 92 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49956252 |
| 93 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49462551 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48582424 |
| 95 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48104269 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47662133 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.45672165 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.45615698 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45478687 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45457487 |
| 101 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.45167168 |
| 102 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.44844041 |
| 103 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.44757105 |
| 104 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44619617 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44158291 |
| 106 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44056646 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.43163637 |
| 108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.43146431 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42396024 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41588477 |
| 111 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41562131 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41459272 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41398190 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41388080 |
| 115 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40780244 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40434596 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39542696 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.39463750 |
| 119 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.39302491 |
| 120 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38576615 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.38489540 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38148878 |
| 123 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.37221519 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37172173 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36485845 |
| 126 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.36166719 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.35775353 |
| 128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.34842857 |
| 129 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.34826004 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.34545332 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.34528768 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.33995445 |
| 133 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33992796 |
| 134 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33640490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31496211 |
| 2 | MP0005360_urolithiasis | 7.46757649 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.47146170 |
| 4 | MP0005365_abnormal_bile_salt | 6.18606112 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19763123 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.17785390 |
| 7 | MP0003252_abnormal_bile_duct | 3.93370918 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61289789 |
| 9 | MP0009840_abnormal_foam_cell | 3.38196306 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04871803 |
| 11 | MP0003195_calcinosis | 2.79510854 |
| 12 | MP0005332_abnormal_amino_acid | 2.76051332 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56454684 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.40544065 |
| 15 | MP0000609_abnormal_liver_physiology | 2.19987940 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11241293 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11061566 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.95642911 |
| 19 | MP0003868_abnormal_feces_composition | 1.93496692 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.86087691 |
| 21 | MP0003011_delayed_dark_adaptation | 1.66621913 |
| 22 | MP0001764_abnormal_homeostasis | 1.64330018 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55686858 |
| 24 | MP0005451_abnormal_body_composition | 1.53653834 |
| 25 | MP0009697_abnormal_copulation | 1.52077879 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.28298660 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.27075903 |
| 28 | MP0003186_abnormal_redox_activity | 1.26114605 |
| 29 | MP0002254_reproductive_system_inflammat | 1.22970244 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.20579828 |
| 31 | MP0000598_abnormal_liver_morphology | 1.20432728 |
| 32 | MP0005647_abnormal_sex_gland | 1.11374380 |
| 33 | MP0000604_amyloidosis | 1.06617141 |
| 34 | MP0002282_abnormal_trachea_morphology | 1.05546223 |
| 35 | MP0009764_decreased_sensitivity_to | 1.04410455 |
| 36 | MP0009763_increased_sensitivity_to | 1.02154192 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.97092217 |
| 38 | MP0005670_abnormal_white_adipose | 0.94289679 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.89012602 |
| 40 | MP0008469_abnormal_protein_level | 0.87818076 |
| 41 | MP0002249_abnormal_larynx_morphology | 0.86710062 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.86188196 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.84348963 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.82420927 |
| 45 | MP0001915_intracranial_hemorrhage | 0.81453553 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.78298957 |
| 47 | MP0005408_hypopigmentation | 0.78133933 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.77622586 |
| 49 | MP0003879_abnormal_hair_cell | 0.75404455 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.73751097 |
| 51 | MP0002971_abnormal_brown_adipose | 0.72061143 |
| 52 | MP0005266_abnormal_metabolism | 0.70888400 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.68171649 |
| 54 | MP0005334_abnormal_fat_pad | 0.67795241 |
| 55 | MP0006035_abnormal_mitochondrial_morpho | 0.66820552 |
| 56 | MP0003690_abnormal_glial_cell | 0.65163652 |
| 57 | MP0004130_abnormal_muscle_cell | 0.65001043 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.64668769 |
| 59 | MP0009785_altered_susceptibility_to | 0.64016570 |
| 60 | MP0005535_abnormal_body_temperature | 0.63046350 |
| 61 | MP0009053_abnormal_anal_canal | 0.62919236 |
| 62 | MP0005023_abnormal_wound_healing | 0.62249255 |
| 63 | MP0005187_abnormal_penis_morphology | 0.61631801 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.61611146 |
| 65 | MP0001661_extended_life_span | 0.61403773 |
| 66 | MP0003329_amyloid_beta_deposits | 0.58307972 |
| 67 | MP0001756_abnormal_urination | 0.57919939 |
| 68 | MP0005448_abnormal_energy_balance | 0.54669971 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.51131483 |
| 70 | MP0005395_other_phenotype | 0.46604816 |
| 71 | MP0008873_increased_physiological_sensi | 0.46571289 |
| 72 | MP0002822_catalepsy | 0.45888257 |
| 73 | MP0008874_decreased_physiological_sensi | 0.45692235 |
| 74 | MP0000566_synostosis | 0.45451723 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.45427932 |
| 76 | MP0005248_abnormal_Harderian_gland | 0.44678381 |
| 77 | MP0000467_abnormal_esophagus_morphology | 0.44640173 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.43670204 |
| 79 | MP0006292_abnormal_olfactory_placode | 0.43512551 |
| 80 | MP0002928_abnormal_bile_duct | 0.43092890 |
| 81 | MP0003718_maternal_effect | 0.42956604 |
| 82 | MP0003436_decreased_susceptibility_to | 0.42831696 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.41849412 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.41230210 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.41230210 |
| 86 | MP0008872_abnormal_physiological_respon | 0.40027378 |
| 87 | MP0003075_altered_response_to | 0.39906104 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.39723176 |
| 89 | MP0003953_abnormal_hormone_level | 0.38855001 |
| 90 | MP0006082_CNS_inflammation | 0.38074592 |
| 91 | MP0004381_abnormal_hair_follicle | 0.37549990 |
| 92 | MP0009115_abnormal_fat_cell | 0.36455221 |
| 93 | MP0002970_abnormal_white_adipose | 0.36331950 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.36294191 |
| 95 | MP0003724_increased_susceptibility_to | 0.36185281 |
| 96 | MP0009672_abnormal_birth_weight | 0.35889989 |
| 97 | MP0004883_abnormal_blood_vessel | 0.35871887 |
| 98 | MP0001243_abnormal_dermal_layer | 0.34672220 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.34416248 |
| 100 | MP0005166_decreased_susceptibility_to | 0.34368619 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.34239893 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.33969771 |
| 103 | MP0000249_abnormal_blood_vessel | 0.33264825 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.31477154 |
| 105 | MP0001853_heart_inflammation | 0.30778551 |
| 106 | MP0000579_abnormal_nail_morphology | 0.30747024 |
| 107 | MP0002796_impaired_skin_barrier | 0.30674334 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.29319027 |
| 109 | MP0002168_other_aberrant_phenotype | 0.28234489 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.27568337 |
| 111 | MP0002132_abnormal_respiratory_system | 0.27362744 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.26988786 |
| 113 | MP0001881_abnormal_mammary_gland | 0.26804826 |
| 114 | MP0005164_abnormal_response_to | 0.25752399 |
| 115 | MP0001851_eye_inflammation | 0.25557754 |
| 116 | MP0002090_abnormal_vision | 0.22375906 |
| 117 | MP0002128_abnormal_blood_circulation | 0.22004451 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.19869394 |
| 119 | MP0003878_abnormal_ear_physiology | 0.19506288 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.19506288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46966171 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.44203445 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.20504006 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75944458 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.54031429 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.45379301 |
| 7 | Xanthomatosis (HP:0000991) | 6.42099837 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.73839062 |
| 9 | Complement deficiency (HP:0004431) | 5.24823933 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.87746299 |
| 11 | Joint hemorrhage (HP:0005261) | 4.82226173 |
| 12 | Hyperammonemia (HP:0001987) | 4.64670523 |
| 13 | Epidermoid cyst (HP:0200040) | 4.52791330 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47770345 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45925940 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.41568146 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.37427464 |
| 18 | Hyperglycinemia (HP:0002154) | 4.31308932 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29159569 |
| 20 | Ketosis (HP:0001946) | 4.28450342 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.20150574 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08244579 |
| 23 | Nephritis (HP:0000123) | 4.05530329 |
| 24 | Fat malabsorption (HP:0002630) | 4.00460043 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91835349 |
| 26 | Hyperglycinuria (HP:0003108) | 3.89011651 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88800174 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.85844023 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85844023 |
| 30 | Abnormality of complement system (HP:0005339) | 3.84757507 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.78775724 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.65892798 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57735318 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37239539 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.35711956 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32018425 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.30768649 |
| 38 | Spontaneous abortion (HP:0005268) | 3.11461593 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10992097 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.05219959 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 3.03105438 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.02600375 |
| 43 | Steatorrhea (HP:0002570) | 3.01213313 |
| 44 | Ketoacidosis (HP:0001993) | 2.98028894 |
| 45 | Myocardial infarction (HP:0001658) | 2.91928363 |
| 46 | Skin nodule (HP:0200036) | 2.91040760 |
| 47 | Metabolic acidosis (HP:0001942) | 2.79747550 |
| 48 | Neonatal hypoglycemia (HP:0001998) | 2.77465261 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.70570471 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.65383951 |
| 51 | Gout (HP:0001997) | 2.63629159 |
| 52 | Purpura (HP:0000979) | 2.60792193 |
| 53 | Lethargy (HP:0001254) | 2.59342024 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57678604 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.57678604 |
| 56 | Vascular calcification (HP:0004934) | 2.52822270 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.49107112 |
| 58 | Spastic diplegia (HP:0001264) | 2.48443501 |
| 59 | Fair hair (HP:0002286) | 2.47044395 |
| 60 | Cholecystitis (HP:0001082) | 2.45165881 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.45165881 |
| 62 | Acanthocytosis (HP:0001927) | 2.45023979 |
| 63 | Cholelithiasis (HP:0001081) | 2.44991655 |
| 64 | Amyloidosis (HP:0011034) | 2.44810930 |
| 65 | Irritability (HP:0000737) | 2.40261537 |
| 66 | Malnutrition (HP:0004395) | 2.39927013 |
| 67 | Glomerulonephritis (HP:0000099) | 2.39364839 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.39158485 |
| 69 | Cerebral edema (HP:0002181) | 2.37141753 |
| 70 | Mitral stenosis (HP:0001718) | 2.36409500 |
| 71 | Pulmonary embolism (HP:0002204) | 2.35891064 |
| 72 | Neonatal onset (HP:0003623) | 2.30910467 |
| 73 | Gingival bleeding (HP:0000225) | 2.30045769 |
| 74 | Osteomalacia (HP:0002749) | 2.26199882 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24902588 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.23483592 |
| 77 | Enlarged kidneys (HP:0000105) | 2.18661009 |
| 78 | Menorrhagia (HP:0000132) | 2.17055452 |
| 79 | Brushfield spots (HP:0001088) | 2.16174356 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15462872 |
| 81 | Esophageal varix (HP:0002040) | 2.15267820 |
| 82 | Pancreatitis (HP:0001733) | 2.13566873 |
| 83 | Thrombophlebitis (HP:0004418) | 2.09727079 |
| 84 | Late onset (HP:0003584) | 2.09168402 |
| 85 | Vomiting (HP:0002013) | 2.08670613 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.06913034 |
| 87 | Abnormal cartilage morphology (HP:0002763) | 2.03653953 |
| 88 | Joint swelling (HP:0001386) | 2.03258409 |
| 89 | Abnormality of the gallbladder (HP:0005264) | 2.01351674 |
| 90 | Hemorrhage of the eye (HP:0011885) | 1.99690209 |
| 91 | Poikilocytosis (HP:0004447) | 1.98169328 |
| 92 | Opisthotonus (HP:0002179) | 1.97448070 |
| 93 | Generalized aminoaciduria (HP:0002909) | 1.96965753 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 1.95790705 |
| 95 | Rickets (HP:0002748) | 1.94421355 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.94262887 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90898857 |
| 98 | Increased serum ferritin (HP:0003281) | 1.88478356 |
| 99 | Status epilepticus (HP:0002133) | 1.88160470 |
| 100 | Epistaxis (HP:0000421) | 1.87589064 |
| 101 | Gangrene (HP:0100758) | 1.82584250 |
| 102 | Hyperphosphaturia (HP:0003109) | 1.82448729 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81242568 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 1.80987873 |
| 105 | Elevated hepatic transaminases (HP:0002910) | 1.80726713 |
| 106 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80180115 |
| 107 | Renal cortical cysts (HP:0000803) | 1.77877977 |
| 108 | Hydroxyprolinuria (HP:0003080) | 1.76914577 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 1.76914577 |
| 110 | Alkalosis (HP:0001948) | 1.75486136 |
| 111 | Hyperuricemia (HP:0002149) | 1.75293341 |
| 112 | Increased purine levels (HP:0004368) | 1.75293341 |
| 113 | Reticulocytosis (HP:0001923) | 1.74672347 |
| 114 | Abnormality of the Achilles tendon (HP:0005109) | 1.74210750 |
| 115 | Reduced antithrombin III activity (HP:0001976) | 1.72649501 |
| 116 | Atrioventricular block (HP:0001678) | 1.72399901 |
| 117 | Generalized hypopigmentation of hair (HP:0011358) | 1.70717702 |
| 118 | Bifid scrotum (HP:0000048) | 1.67982328 |
| 119 | Abnormal delivery (HP:0001787) | 1.64178737 |
| 120 | Cerebral palsy (HP:0100021) | 1.62740600 |
| 121 | Arthropathy (HP:0003040) | 1.62191115 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.56058842 |
| 123 | Glycosuria (HP:0003076) | 1.56058842 |
| 124 | Increased mean platelet volume (HP:0011877) | 1.55113498 |
| 125 | Abnormality of vitamin metabolism (HP:0100508) | 1.54291786 |
| 126 | Increased serum pyruvate (HP:0003542) | 1.53719506 |
| 127 | Blue irides (HP:0000635) | 1.53080564 |
| 128 | Abnormal urine phosphate concentration (HP:0012599) | 1.49547037 |
| 129 | Abnormal biliary tract physiology (HP:0012439) | 1.49153994 |
| 130 | Bile duct proliferation (HP:0001408) | 1.49153994 |
| 131 | Abnormal platelet function (HP:0011869) | 1.45933565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.06020348 |
| 2 | ERN1 | 5.13759847 |
| 3 | FGFR4 | 4.41226504 |
| 4 | SIK1 | 4.36208443 |
| 5 | TAOK3 | 2.89997692 |
| 6 | INSRR | 2.79174302 |
| 7 | ERBB4 | 2.78927909 |
| 8 | MAP2K4 | 2.50299439 |
| 9 | PKN2 | 2.24626040 |
| 10 | NTRK3 | 2.18393644 |
| 11 | PIK3CA | 1.97799527 |
| 12 | MST1R | 1.93990412 |
| 13 | FLT3 | 1.92570559 |
| 14 | MAPK11 | 1.82951147 |
| 15 | TRIB3 | 1.80216615 |
| 16 | GRK6 | 1.77836893 |
| 17 | TYK2 | 1.65563145 |
| 18 | LATS1 | 1.57309300 |
| 19 | PIK3CG | 1.55462080 |
| 20 | ABL2 | 1.46506856 |
| 21 | PTK6 | 1.37889869 |
| 22 | DAPK2 | 1.35755017 |
| 23 | MAP3K7 | 1.26975740 |
| 24 | TNK2 | 1.25903085 |
| 25 | MAP3K10 | 1.23689606 |
| 26 | KDR | 1.22586463 |
| 27 | NEK9 | 1.21484842 |
| 28 | FGFR2 | 1.21240822 |
| 29 | PRPF4B | 1.20653892 |
| 30 | JAK2 | 1.19632903 |
| 31 | PINK1 | 1.11265997 |
| 32 | PRKAA2 | 1.07300516 |
| 33 | BLK | 1.07085965 |
| 34 | ERBB2 | 1.06556881 |
| 35 | FRK | 1.05691015 |
| 36 | MAP2K3 | 1.05162573 |
| 37 | NLK | 1.04907486 |
| 38 | MAPK4 | 1.04509040 |
| 39 | TBK1 | 0.98109095 |
| 40 | CSF1R | 0.96726704 |
| 41 | TGFBR2 | 0.95831606 |
| 42 | GRK1 | 0.94910918 |
| 43 | MAPK7 | 0.94031051 |
| 44 | MAPK12 | 0.91829676 |
| 45 | JAK1 | 0.91596028 |
| 46 | FER | 0.90020796 |
| 47 | PRKCZ | 0.86797469 |
| 48 | CSK | 0.84967708 |
| 49 | MAP3K3 | 0.83570110 |
| 50 | MAP3K14 | 0.82897076 |
| 51 | PRKG1 | 0.82319158 |
| 52 | MAP2K6 | 0.81319759 |
| 53 | EPHB1 | 0.81234764 |
| 54 | MET | 0.80990799 |
| 55 | STK38L | 0.80175914 |
| 56 | MAPK15 | 0.77674927 |
| 57 | CDK6 | 0.77431568 |
| 58 | PRKACA | 0.77397582 |
| 59 | PRKACG | 0.77289012 |
| 60 | MAP3K11 | 0.73665842 |
| 61 | PDK2 | 0.73420098 |
| 62 | DYRK1B | 0.72235024 |
| 63 | MAP3K2 | 0.72050977 |
| 64 | CAMKK2 | 0.71749812 |
| 65 | EPHA3 | 0.71701147 |
| 66 | ZAP70 | 0.70124533 |
| 67 | FGFR3 | 0.69468469 |
| 68 | GSK3A | 0.68654229 |
| 69 | TIE1 | 0.67331922 |
| 70 | CAMK2G | 0.64410072 |
| 71 | PRKAA1 | 0.63366197 |
| 72 | RIPK1 | 0.60876506 |
| 73 | PTK2 | 0.60051416 |
| 74 | CAMK1D | 0.56724285 |
| 75 | SGK3 | 0.54701838 |
| 76 | CAMK4 | 0.54594339 |
| 77 | IRAK3 | 0.53569910 |
| 78 | CSNK1E | 0.52785206 |
| 79 | TAOK2 | 0.50496295 |
| 80 | SGK494 | 0.49750065 |
| 81 | RPS6KA3 | 0.49543163 |
| 82 | GRK5 | 0.48799722 |
| 83 | MAP4K1 | 0.48414965 |
| 84 | CDK4 | 0.47952990 |
| 85 | IGF1R | 0.47617138 |
| 86 | CAMKK1 | 0.47260959 |
| 87 | PRKCQ | 0.47112137 |
| 88 | CSNK1D | 0.46972823 |
| 89 | PDPK1 | 0.46411104 |
| 90 | PRKCB | 0.45304878 |
| 91 | IKBKE | 0.44845687 |
| 92 | MAP3K5 | 0.44737360 |
| 93 | MTOR | 0.42220229 |
| 94 | SRC | 0.41901550 |
| 95 | SGK1 | 0.40951542 |
| 96 | PRKCG | 0.40947006 |
| 97 | EPHA4 | 0.39896803 |
| 98 | CDK12 | 0.38955159 |
| 99 | CSNK1G1 | 0.38712909 |
| 100 | ICK | 0.38671365 |
| 101 | LATS2 | 0.37654999 |
| 102 | SMG1 | 0.37599698 |
| 103 | EPHA2 | 0.37209055 |
| 104 | PDGFRA | 0.37110960 |
| 105 | CSNK2A1 | 0.36641751 |
| 106 | WNK4 | 0.35753611 |
| 107 | MAP2K1 | 0.34890719 |
| 108 | RET | 0.34888196 |
| 109 | EGFR | 0.33866020 |
| 110 | PKN1 | 0.33795731 |
| 111 | MAP3K6 | 0.32965651 |
| 112 | SGK2 | 0.32416852 |
| 113 | PDK1 | 0.32026192 |
| 114 | ADRBK2 | 0.29471657 |
| 115 | CSNK2A2 | 0.29032410 |
| 116 | MAP3K13 | 0.28769162 |
| 117 | MYLK | 0.28058041 |
| 118 | KSR2 | 0.27571290 |
| 119 | AKT3 | 0.24748596 |
| 120 | BMX | 0.23626012 |
| 121 | PRKCA | 0.23067257 |
| 122 | MAP3K1 | 0.20540036 |
| 123 | ABL1 | 0.20472137 |
| 124 | MAP2K2 | 0.19629106 |
| 125 | ITK | 0.19380692 |
| 126 | MAPK3 | 0.18904409 |
| 127 | PRKACB | 0.18562961 |
| 128 | IRAK2 | 0.18332585 |
| 129 | CSNK1G2 | 0.18152693 |
| 130 | SGK223 | 0.18105818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.51944241 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54721536 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43635809 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34416362 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09514871 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79050287 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74707182 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68454579 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60455213 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55934809 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49077786 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38009227 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29869650 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12437077 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11600667 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08318031 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97180852 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97110227 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91431968 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89968110 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88692540 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87451715 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79995298 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76864669 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76318524 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74152081 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69604057 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68845235 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67234565 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65755399 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59701253 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58733657 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55856997 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52272572 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.49674242 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49581403 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42706076 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35284801 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35266847 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32737956 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28720975 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27718443 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24417101 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22811577 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19591409 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16902571 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14078559 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13086261 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06734110 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00518140 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98853098 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97896769 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96449470 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96301355 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96093872 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87319737 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84117328 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83989892 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81392817 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76242516 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73168917 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68197610 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63512906 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60384758 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49542063 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46498799 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46274997 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.46090525 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36974786 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33803317 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.33730261 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32647382 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31568617 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26861528 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.24694824 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24248611 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18473455 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15721789 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.11854013 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10568168 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.08696593 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04579154 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04257469 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2787956 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2745330 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2675784 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | -0.2414064 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2403887 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2351388 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2328242 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2326528 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2287803 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2158580 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2084553 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2054389 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1937357 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1913349 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1747076 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1674791 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1404965 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1335819 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1283402 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1264403 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1203402 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1036244 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1012029 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0681437 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0541244 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0522980 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0400298 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0396356 |

